PTEN Status in Sporadic and Cowden Syndrome-Associated Trichilemmomas: Evaluation of Immunohistochemistry and Fluorescence In Situ Hybridization

被引：0
|
作者：
Sukov, W. R. [1 ]
Shon, W. [1 ]
Wolz, M. M. [1 ]
Wieland, C. N. [1 ]
Gibson, L. E. [1 ]
Peters, M. S. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
505
引用
收藏
页码：122A / 122A
页数：1
相关论文
共 50 条
  • [21] Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers
    Wang, Mopei
    Liang, Li
    Lei, Xiudong
    Multani, Asha
    Meric-Bernstam, Funda
    Tripathy, Debasish
    Wu, Yun
    Chen, Hui
    Zhang, Hong
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 35 : 69 - 76
  • [22] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    Wang, Lin
    Wang, Xiaobei
    Nie, Xiu
    Ma, Ling
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (03) : 354 - 358
  • [23] Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients
    Lin Wang
    Xiaobei Wang
    Xiu Nie
    Ling Ma
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 354 - 358
  • [24] - COUNTERPOINT - Both Immunohistochemistry and Fluorescence In Situ Hybridization Play Important Roles for HER2 Evaluation
    Bloom, Kenneth J.
    Cote, Richard J.
    CLINICAL CHEMISTRY, 2011, 57 (07) : 983 - 985
  • [25] Fluorescence in situ hybridization (FISH) is superior to immunohistochemistry (IHC) for determining HER2 status:: The Herceptin® experience
    Press, M
    Anderson, S
    Dybdal, N
    Lieberman, G
    Mass, R
    LABORATORY INVESTIGATION, 2002, 82 (01) : 47A - 48A
  • [26] Fluorescence in situ hybridization (FISH) is superior to immunohistochemistry (IHC) for determining HER2 status:: The Herceptin® experience
    Press, M
    Anderson, S
    Dybdal, N
    Lieberman, G
    Mass, R
    MODERN PATHOLOGY, 2002, 15 (01) : 47A - 48A
  • [27] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Weiguo Sui
    Minglin Ou
    Jiejing Chen
    Youhua Wan
    Hongbo Peng
    Minfang Qi
    He Huang
    Yong Dai
    World Journal of Surgical Oncology, 7
  • [28] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Sui, Weiguo
    Ou, Minglin
    Chen, Jiejing
    Wan, Youhua
    Peng, Hongbo
    Qi, Minfang
    Huang, He
    Dai, Yong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7 : 83
  • [29] Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization
    Huang, Richard S. P.
    Smith, Derek
    Le, Catherine H.
    Liu, Wen-Wei
    Ordinario, Ellen
    Manohar, Chitra
    Lee, Michael
    Rajamani, Jaya
    Truong, Huan
    Li, Jing
    Choi, Cindy
    Li, Jingchuan
    Pati, Amrita
    Bubendorf, Lukas
    Buettner, Reinhard
    Kerr, Keith M.
    Lopez-Rios, Fernando
    Marchetti, Antonio
    Marondel, Ivonne
    Nicholson, Andrew G.
    Oz, Aysim Buge
    Pauwels, Patrick
    Penault-Llorca, Frederique
    Rossi, Giulio
    Thunnissen, Erik
    Newell, Amy Hanlon
    Pate, Greg
    Menzl, Ina
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (06) : 735 - 741
  • [30] Evaluation of HER-2/neu status in breast cancer specimens using immunohistochemistry (IHC) & fluorescence in-situ hybridization (FISH) assay
    Goud, Kalal Iravathy
    Dayakar, Seetha
    Vijayalaxmi, Kolanupaka
    Babu, Saidam Jangu
    Reddy, Vijay Anand P.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2012, 135 (03) : 312 - 317
12345